Gary D. Glick
CIK: 0002051249
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ODTX
Odyssey Therapeutics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Glick Gary D
Glick Gary D (SEC CIK 0002051249) files insider reports with the SEC as Director of Odyssey Therapeutics, Inc. (ODTX).
Signal8 holds 2 ownership filings by Glick Gary D (1 Form 3, 1 Form 4), filed between May 7, 2026 and May 11, 2026. Those filings report 2 transactions, from May 7, 2026 to May 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Glick Gary D's filings is in BOSTON, MA.
Recent filings by Glick Gary D
Other insiders filing for Odyssey Therapeutics, Inc. (ODTX)
- TPG GP A, LLC, Officer
- Dimension Capital II, L.P., Director
- SR ONE CAPITAL MANAGEMENT, LLC, 10% Owner
- LEIDEN JEFFREY M, Director
- Haas Jason, Chief Financial Officer
- Li Nan (LN), Director